title: Prognosis of acquired hemophilia in older people.
authors.forename: Stéphane
authors.initials: S
authors.lastname: Girault
authors.forename: Kim
authors.initials: K
authors.lastname: Ly
authors.forename: Arnaud
authors.initials: A
authors.lastname: Jaccard
authors.forename: Véronique
authors.initials: V
authors.lastname: Loustaud
authors.forename: Pascal
authors.initials: P
authors.lastname: Turlure
authors.forename: Annie
authors.initials: A
authors.lastname: Julia
authors.forename: Dominique
authors.initials: D
authors.lastname: Bordessoule
authors.forename: Elisabeth
authors.initials: E
authors.lastname: Vidal
authors.forename: Eric
authors.initials: E
authors.lastname: Liozon
mesh_terms: D000368:Aged; D000369:Aged, 80 and over; D001323:Autoantibodies / Q000097:blood; D015982:Bias; D003422:Critical Care; D005169:Factor VIII / Q000276:immunology; D005260:Female; D006467:Hemophilia A / Q000209:etiology / Q000401:mortality* / Q000628:therapy*; D006470:Hemorrhage / Q000209:etiology / Q000401:mortality / Q000628:therapy; D006801:Humans; D008297:Male; D010314:Partial Thromboplastin Time; D011379:Prognosis; D012189:Retrospective Studies; D015996:Survival Rate; D016896:Treatment Outcome
chemical_list: D001323:Autoantibodies; D005169:Factor VIII